was

DATROWAY Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival as First-Line Therapy for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02

Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to significantly improve overall survival versus chemotherapy in this…

3 weeks ago

The 12th World Congress on High-Speed Rail Was Held in Beijing

MODERN RAILWAYS 2025 Held Concurrently BEIJING, July 10, 2025 /PRNewswire/ -- A news report from China Daily: According to China…

4 months ago